
Sanofi, Formation Bio and OpenAI have announced that they have entered into a collaboration with the aim of building AI-powered …

ERS Genomics and IRBM have announced that they have entered into a non-exclusive CRISPR/Cas9 license agreement, granting IRBM access to …

Sanofi has announced that it has made a new investment of at least โฌ1bn for the creation of new bioproduction …

AbbVie has announced that it is investing approximately โฌ150m in its second largest research and development (R&D) facility worldwide. The …

Beckman Coulter Life Sciences and Watchmaker Genomics have announced that they have entered into a collaborative partnership with the aim …

PeptiDream has announced the expansion of its peptide discovery collaboration with Novartis Pharma AG.

Regeneron Pharmaceuticals and Mammoth Biosciences have announced a collaboration for the research, development and commercialisation of in vivo CRISPR-based gene …

ANGLE has announced that it has signed a supplier agreement with AstraZeneca for the development and validation of a methodology …

Eli Lilly and Nexus Pharmaceuticals have announced that they have entered into a definitive agreement for Eli Lilly to acquire …

Ardena has announced that it has received Good Manufacturing Practice (GMP) approval from the Dutch Healthcare Authority for its new …

Baxter International has announced the continued expansion of its pharmaceuticals portfolio with the launch of five new injectable products in …

UCB has announced that the US Food and Drug Administration (FDA) has accepted for review its supplemental Biologics License Application …

Healthcare agencies can submit their entries free of charge with a deadline of 30 April The 2024 edition of PMLiVEโs …

Abenza has announced a major investment in bioconjugation and antibody drug conjugate (ADC) capabilities in response to an increasing industry …

AbbVie and Landos Biopharma have announced that they have entered into a definitive agreement under which AbbVie will acquire Landos …